HALO Halozyme Therapeutics, Inc.

$107.20▲ +0.19% Healthcare Other
After hours $107.20▲ +0.00% Sep 11, 7:30 PM ET
Volume 861.3K Avg Volume (10D) 1.47M
Key Metrics & Fundamentals
Market Cap
$12.17B
P/E Ratio
31.4
Div Yield
–%
52W Range
61.23 - 111.15
% vs 50 MA
15.13%
% vs 200 MA
43.01%
RSI-14
62.5
MACD Histogram
-1.0800
Beta (1Y vs SPY)
0.56
Free Cash Flow
$236.72M
Gross Rev
$481.00M
Gross Profit
$401.83M
EBITDA
$321.62M
COGS
$79.17M
Operating Exp
$114.17M
Operating Income
$287.65M
EBIT
$287.65M
Pretax Income
$284.90M
Net Income
$229.91M
EPS (Diluted)
1.90
Price & Volume History
Loading chart…
Financial Overview - Income Statement Quarterly

See HALO's money flow as a full page

AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙